Anastrozole

Therapeutic indications

Anastrozole is indicated for:

Population group: women, only adults (18 years old or older)

Anastrozole is indicated for the:

Treatment of hormone receptor-positive advanced breast cancer in postmenopausal women.
Adjuvant treatment of hormone receptor-positive early invasive breast cancer in postmenopausal women.
Adjuvant treatment of hormone receptor-positive early invasive breast cancer in postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Anastrozole is contraindicated in the following cases: